These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting peroxynitrite driven nitroxidative stress with synzymes: A novel therapeutic approach in chronic pain management. Salvemini D; Neumann W Life Sci; 2010 Apr; 86(15-16):604-14. PubMed ID: 19576230 [TBL] [Abstract][Full Text] [Related]
3. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways. Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. Muscoli C; Cuzzocrea S; Ndengele MM; Mollace V; Porreca F; Fabrizi F; Esposito E; Masini E; Matuschak GM; Salvemini D J Clin Invest; 2007 Nov; 117(11):3530-9. PubMed ID: 17975673 [TBL] [Abstract][Full Text] [Related]
5. Opioid tolerance and neuroplasticity. Mao J Novartis Found Symp; 2004; 261():181-6; discussion 187-93. PubMed ID: 15469051 [TBL] [Abstract][Full Text] [Related]
6. Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation. Ndengele MM; Cuzzocrea S; Masini E; Vinci MC; Esposito E; Muscoli C; Petrusca DN; Mollace V; Mazzon E; Li D; Petrache I; Matuschak GM; Salvemini D J Pharmacol Exp Ther; 2009 Apr; 329(1):64-75. PubMed ID: 19033555 [TBL] [Abstract][Full Text] [Related]
7. Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance. Doyle T; Bryant L; Batinic-Haberle I; Little J; Cuzzocrea S; Masini E; Spasojevic I; Salvemini D Neuroscience; 2009 Dec; 164(2):702-10. PubMed ID: 19607887 [TBL] [Abstract][Full Text] [Related]
8. When it comes to opiates, just say NO. Pasternak GW J Clin Invest; 2007 Nov; 117(11):3185-7. PubMed ID: 17975665 [TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Szabó C; Ischiropoulos H; Radi R Nat Rev Drug Discov; 2007 Aug; 6(8):662-80. PubMed ID: 17667957 [TBL] [Abstract][Full Text] [Related]
10. The ambiguities of opioid tolerance mechanisms: barriers to pain therapeutics or new pain therapeutic possibilities. Gintzler AR; Chakrabarti S J Pharmacol Exp Ther; 2008 Jun; 325(3):709-13. PubMed ID: 18354057 [TBL] [Abstract][Full Text] [Related]
11. Interaction of the cannabinoid and opioid systems in the modulation of nociception. Welch SP Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508 [TBL] [Abstract][Full Text] [Related]
12. Nitrogen, oxygen or sulfur containing heterocyclic compounds as analgesic drugs used as modulators of the nitroxidative stress. Salat K; Moniczewski A; Librowski T Mini Rev Med Chem; 2013 Mar; 13(3):335-52. PubMed ID: 22876956 [TBL] [Abstract][Full Text] [Related]
13. Peroxynitrite and opiate antinociceptive tolerance: a painful reality. Salvemini D Arch Biochem Biophys; 2009 Apr; 484(2):238-44. PubMed ID: 19017525 [No Abstract] [Full Text] [Related]
14. The chemistry of peroxynitrite: implications for biological activity. Goldstein S; Merényi G Methods Enzymol; 2008; 436():49-61. PubMed ID: 18237627 [TBL] [Abstract][Full Text] [Related]
15. Metalloporphyrins as a therapeutic drug class against peroxynitrite in cardiovascular diseases involving ischemic reperfusion injury. Rabkin SW; Klassen SS Eur J Pharmacol; 2008 May; 586(1-3):1-8. PubMed ID: 18395709 [TBL] [Abstract][Full Text] [Related]
16. The formation of peroxynitrite in the applied physiology of mitochondrial nitric oxide. Poderoso JJ Arch Biochem Biophys; 2009 Apr; 484(2):214-20. PubMed ID: 19159609 [TBL] [Abstract][Full Text] [Related]
17. Post-radiation syndrome as a NO/ONOO- cycle, chronic fatigue syndrome-like disease. Pall ML Med Hypotheses; 2008 Oct; 71(4):537-41. PubMed ID: 18667279 [TBL] [Abstract][Full Text] [Related]
19. Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Arendt-Nielsen L; Olesen AE; Staahl C; Menzaghi F; Kell S; Wong GY; Drewes AM Anesthesiology; 2009 Sep; 111(3):616-24. PubMed ID: 19672186 [TBL] [Abstract][Full Text] [Related]
20. System theory of pain and of opiate analgesia: no tolerance to opiates. Colpaert FC Pharmacol Rev; 1996 Sep; 48(3):355-402. PubMed ID: 8888306 [No Abstract] [Full Text] [Related] [Next] [New Search]